Mr. Stephen Kilmer reports

INTELGENX TO REPORT FIRST QUARTER 2023 FINANCIAL RESULTS ON MAY 11, 2023 - CONFERENCE CALL TO FOLLOW

IntelGenx Technologies Corp. will release its first quarter 2023 financial results after the market close on Thursday, May 11, 2023.

An accompanying conference call will be hosted by Dr. Horst G. Zerbe, chairman, Dwight Gorham, chief executive officer, and Andre Godin, president and chief financial officer, to discuss the results and provide a business update. Details of the conference call and webcast are below.

First quarter 2023 results conference call details

Date:  Thursday, May 11, 2023

Time:  4:30 p.m. ET

Live call:  1-888-506-0062 (Canada and the United States) or 1-973-528-0011 (international)

Access code:  655475

The call will also be broadcast live and archived on the company's website under webcasts in the investors section.

About IntelGenx Technologies Corp.

IntelGenx is a leading drug delivery company focused on the development and manufacturing of pharmaceutical films.

IntelGenx's superior film technologies, including VersaFilm, DisinteQ, VetaFilm and transdermal VevaDerm, allow for next-generation pharmaceutical products that address unmet medical needs. IntelGenx's innovative product pipeline offers significant benefits to patients and physicians for many therapeutic conditions.

IntelGenx's highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D (research and development), analytical method development, clinical monitoring, IP and regulatory services. IntelGenx's state-of-the-art manufacturing facility offers full service by providing lab-scale to pilot- and commercial-scale production.

We seek Safe Harbor.